Profile
Jens Schneider-Mergener is the founder of Pharvaris NV, which was founded in 2015.
He was the Chief Executive Officer at Shire Orphan Therapies GmbH.
He also served as the Chief Executive Officer at AdrenoMed AG from 2019 to 2021.
Dr. Schneider-Mergener received his undergraduate degree from the University of Bielefeld and his doctorate from Ludwig-Maximilians-Universität München.
Former positions of Jens Schneider-Mergener
| Companies | Position | End |
|---|---|---|
AdrenoMed AG
 AdrenoMed AG Pharmaceuticals: MajorHealth Technology AdrenoMed AG develops a drug to decrease mortality in severe sepsis. The company was founded by Bernd Wegener, Gerald Heinz Möller and Andreas Bergmann in 2009 and is headquartered in Berlin, Germany. | Chief Executive Officer | 2020-12-31 |
| PHARVARIS N.V. | Founder | - |
Shire Orphan Therapies GmbH
 Shire Orphan Therapies GmbH Pharmaceuticals: MajorHealth Technology Shire Orphan Therapies GmbH engages in the development, manufacture, and distribution of chemical and biochemical products, ingredients, as well as pharmaceutical and diagnostic products. The company was founded in 1994 and is headquartered in Berlin, Germany. | Chairman | - |
Training of Jens Schneider-Mergener
| University of Bielefeld | Undergraduate Degree |
| Ludwig-Maximilians-Universität München | Doctorate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| PHARVARIS N.V. | Health Technology |
| Private companies | 2 |
|---|---|
Shire Orphan Therapies GmbH
Shire Orphan Therapies GmbH Pharmaceuticals: MajorHealth Technology Shire Orphan Therapies GmbH engages in the development, manufacture, and distribution of chemical and biochemical products, ingredients, as well as pharmaceutical and diagnostic products. The company was founded in 1994 and is headquartered in Berlin, Germany. | Health Technology |
AdrenoMed AG
AdrenoMed AG Pharmaceuticals: MajorHealth Technology AdrenoMed AG develops a drug to decrease mortality in severe sepsis. The company was founded by Bernd Wegener, Gerald Heinz Möller and Andreas Bergmann in 2009 and is headquartered in Berlin, Germany. | Health Technology |
- Stock Market
- Insiders
- Jens Schneider-Mergener
